Տոքսիկ էպիդերմալ նեկրոլիզ (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Տոքսիկ էպիդերմալ նեկրոլիզ" in Armenian language version.

refsWebsite

Global rank Armenian rank

18nih.gov

4^th place

3^rd place

17doi.org

2^nd place

4^th place

4web.archive.org

1^st place

3archive.org

6^th place

2worldcat.org

5^th place

10^th place

1orpha.net

3,537^th place

2,926^th place

1emedicine.com

3,595^th place

1,259^th place

1jamanetwork.com

2,650^th place

1,216^th place

1wiley.com

222^nd place

187^th place

1cochrane.org

7,609^th place

1,774^th place

archive.org

Morales, ME; Purdue, GF; Verity, SM; Arnoldo, BD; Blomquist, PH (October 2010). «Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN». American journal of ophthalmology. 150 (4): 505–510.e1. doi:10.1016/j.ajo.2010.04.026. PMID 20619392.
McCormack, M; Alfirevic, A; Bourgeois, S; Farrell, JJ; Kasperavičiūtė, D; Carrington, M; Sills, GJ; Marson, T; Jia, X; de Bakker, PI; Chinthapalli, K; Molokhia, M; Johnson, MR; O'Connor, GD; Chaila, E; Alhusaini, S; Shianna, KV; Radtke, RA; Heinzen, EL; Walley, N; Pandolfo, M; Pichler, W; Park, BK; Depondt, C; Sisodiya, SM; Goldstein, DB; Deloukas, P; Delanty, N; Cavalleri, GL; Pirmohamed, M (2011 թ․ մարտի 24). «HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans». The New England Journal of Medicine. 364 (12): 1134–43. doi:10.1056/nejmoa1013297. PMC 3113609. PMID 21428769.
DeMers, G; Meurer, WJ; Shih, R; Rosenbaum, S; Vilke, GM (December 2012). «Tissue plasminogen activator and stroke: review of the literature for the clinician». The Journal of emergency medicine. 43 (6): 1149–54. doi:10.1016/j.jemermed.2012.05.005. PMID 22818644.

cochrane.org

Majumdar, Samit; Mockenhaupt, Maja; Roujeau, Jean-Claude; Townshend, Askari P (2002 թ․ հոկտեմբերի 21). «Interventions for toxic epidermal necrolysis». Cochrane Database of Systematic Reviews (անգլերեն). doi:10.1002/14651858.CD001435. ISSN 1465-1858.

doi.org

Adler NR, Aung AK, Ergen EN, Trubiano J, Goh MS, Phillips EJ (2017). «Recent advances in the understanding of severe cutaneous adverse reactions». The British Journal of Dermatology. 177 (5): 1234–1247. doi:10.1111/bjd.15423. PMID 28256714.
Schwartz, RA; McDonough, PH; Lee, BW (August 2013). «Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis». Journal of the American Academy of Dermatology. 69 (2): 173.e1-13, quiz 185–6. doi:10.1016/j.jaad.2013.05.003. PMID 23866878.
Schwartz, RA; McDonough, PH; Lee, BW (August 2013). «Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment». Journal of the American Academy of Dermatology. 69 (2): 187.e1-16, quiz 203–4. doi:10.1016/j.jaad.2013.05.002. PMID 23866879.
Jordan, MH; Lewis, MS; Jeng, JG; Rees, JM (1991). «Treatment of toxic epidermal necrolysis by burn units: another market or another threat?». The Journal of burn care & rehabilitation. 12 (6): 579–81. doi:10.1097/00004630-199111000-00015. PMID 1779014.
Roujeau, JC; Stern, RS (1994 թ․ նոյեմբերի 10). «Severe adverse cutaneous reactions to drugs». The New England Journal of Medicine. 331 (19): 1272–85. doi:10.1056/nejm199411103311906. PMID 7794310.
Morales, ME; Purdue, GF; Verity, SM; Arnoldo, BD; Blomquist, PH (October 2010). «Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN». American journal of ophthalmology. 150 (4): 505–510.e1. doi:10.1016/j.ajo.2010.04.026. PMID 20619392.
Maverakis, Emanual; Wang, Elizabeth A.; Shinkai, Kanade; Mahasirimongkol, Surakameth; Margolis, David J.; Avigan, Mark; Chung, Wen-Hung; Goldman, Jennifer; Grenade, Lois La (2017 թ․ հունիսի 1). «Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group». JAMA Dermatology. 153 (6): 587–592. doi:10.1001/jamadermatol.2017.0160. ISSN 2168-6068.
Hung, SI; Chung, WH; Jee, SH; Chen, WC; Chang, YT; Lee, WR; Hu, SL; Wu, MT; Chen, GS; Wong, TW; Hsiao, PF; Chen, WH; Shih, HY; Fang, WH; Wei, CY; Lou, YH; Huang, YL; Lin, JJ; Chen, YT (April 2006). «Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions». Pharmacogenetics and genomics. 16 (4): 297–306. doi:10.1097/01.fpc.0000199500.46842.4a. PMID 16538176.
McCormack, M; Alfirevic, A; Bourgeois, S; Farrell, JJ; Kasperavičiūtė, D; Carrington, M; Sills, GJ; Marson, T; Jia, X; de Bakker, PI; Chinthapalli, K; Molokhia, M; Johnson, MR; O'Connor, GD; Chaila, E; Alhusaini, S; Shianna, KV; Radtke, RA; Heinzen, EL; Walley, N; Pandolfo, M; Pichler, W; Park, BK; Depondt, C; Sisodiya, SM; Goldstein, DB; Deloukas, P; Delanty, N; Cavalleri, GL; Pirmohamed, M (2011 թ․ մարտի 24). «HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans». The New England Journal of Medicine. 364 (12): 1134–43. doi:10.1056/nejmoa1013297. PMC 3113609. PMID 21428769.
Tohkin, M; Kaniwa, N; Saito, Y; Sugiyama, E; Kurose, K; Nishikawa, J; Hasegawa, R; Aihara, M; Matsunaga, K; Abe, M; Furuya, H; Takahashi, Y; Ikeda, H; Muramatsu, M; Ueta, M; Sotozono, C; Kinoshita, S; Ikezawa, Z; Japan Pharmacogenomics Data Science, Consortium (February 2013). «A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients». The pharmacogenomics journal. 13 (1): 60–9. doi:10.1038/tpj.2011.41. PMID 21912425.
Schwartz, RA; McDonough, PH; Lee, BW (Aug 2013). «Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment». Journal of the American Academy of Dermatology. 69 (2): 187.e1-16, quiz 203–4. doi:10.1016/j.jaad.2013.05.002. PMID 23866879.
Zajicek, R; Pintar, D; Broz, L; Suca, H; Königova, R (May 2012). «Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008». Journal of the European Academy of Dermatology and Venereology : JEADV. 26 (5): 639–43. doi:10.1111/j.1468-3083.2011.04143.x. PMID 21668825.
Rajaratnam R, Mann C, Balasubramaniam P, և այլք: (December 2010). «Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre». Clin. Exp. Dermatol. 35 (8): 853–62. doi:10.1111/j.1365-2230.2010.03826.x. PMID 20456393.
Majumdar, Samit; Mockenhaupt, Maja; Roujeau, Jean-Claude; Townshend, Askari P (2002 թ․ հոկտեմբերի 21). «Interventions for toxic epidermal necrolysis». Cochrane Database of Systematic Reviews (անգլերեն). doi:10.1002/14651858.CD001435. ISSN 1465-1858.
Quinn AM; Brown, K; Bonish, BK; Curry, J; Gordon, KB; Sinacore, J; Gamelli, R; Nickoloff, BJ; և այլք: (2005). «Uncovering histological criteria with prognostic significance in toxic epidermal necrolysis». Arch Dermatol. 141 (6): 683–7. doi:10.1001/archderm.141.6.683. PMID 15967913.
Schwartz, RA; McDonough, PH; Lee, BW (August 2013). «Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment». Journal of the American Academy of Dermatology. 69 (2): 187.e1-16, quiz 203–4. doi:10.1016/j.jaad.2013.05.002. PMID 23866879.
DeMers, G; Meurer, WJ; Shih, R; Rosenbaum, S; Vilke, GM (December 2012). «Tissue plasminogen activator and stroke: review of the literature for the clinician». The Journal of emergency medicine. 43 (6): 1149–54. doi:10.1016/j.jemermed.2012.05.005. PMID 22818644.

emedicine.com

Garra, GP (2007). "Toxic Epidermal Necrolysis Արխիվացված 2007-12-27 Wayback Machine". Emedicine.com. Retrieved on December 13, 2007.

jamanetwork.com

Maverakis, Emanual; Wang, Elizabeth A.; Shinkai, Kanade; Mahasirimongkol, Surakameth; Margolis, David J.; Avigan, Mark; Chung, Wen-Hung; Goldman, Jennifer; Grenade, Lois La (2017 թ․ հունիսի 1). «Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group». JAMA Dermatology. 153 (6): 587–592. doi:10.1001/jamadermatol.2017.0160. ISSN 2168-6068.

nih.gov

pubmed.ncbi.nlm.nih.gov

Adler NR, Aung AK, Ergen EN, Trubiano J, Goh MS, Phillips EJ (2017). «Recent advances in the understanding of severe cutaneous adverse reactions». The British Journal of Dermatology. 177 (5): 1234–1247. doi:10.1111/bjd.15423. PMID 28256714.
Schwartz, RA; McDonough, PH; Lee, BW (August 2013). «Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis». Journal of the American Academy of Dermatology. 69 (2): 173.e1-13, quiz 185–6. doi:10.1016/j.jaad.2013.05.003. PMID 23866878.
Schwartz, RA; McDonough, PH; Lee, BW (August 2013). «Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment». Journal of the American Academy of Dermatology. 69 (2): 187.e1-16, quiz 203–4. doi:10.1016/j.jaad.2013.05.002. PMID 23866879.
Jordan, MH; Lewis, MS; Jeng, JG; Rees, JM (1991). «Treatment of toxic epidermal necrolysis by burn units: another market or another threat?». The Journal of burn care & rehabilitation. 12 (6): 579–81. doi:10.1097/00004630-199111000-00015. PMID 1779014.
Roujeau, JC; Stern, RS (1994 թ․ նոյեմբերի 10). «Severe adverse cutaneous reactions to drugs». The New England Journal of Medicine. 331 (19): 1272–85. doi:10.1056/nejm199411103311906. PMID 7794310.
Morales, ME; Purdue, GF; Verity, SM; Arnoldo, BD; Blomquist, PH (October 2010). «Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN». American journal of ophthalmology. 150 (4): 505–510.e1. doi:10.1016/j.ajo.2010.04.026. PMID 20619392.
Hung, SI; Chung, WH; Jee, SH; Chen, WC; Chang, YT; Lee, WR; Hu, SL; Wu, MT; Chen, GS; Wong, TW; Hsiao, PF; Chen, WH; Shih, HY; Fang, WH; Wei, CY; Lou, YH; Huang, YL; Lin, JJ; Chen, YT (April 2006). «Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions». Pharmacogenetics and genomics. 16 (4): 297–306. doi:10.1097/01.fpc.0000199500.46842.4a. PMID 16538176.
McCormack, M; Alfirevic, A; Bourgeois, S; Farrell, JJ; Kasperavičiūtė, D; Carrington, M; Sills, GJ; Marson, T; Jia, X; de Bakker, PI; Chinthapalli, K; Molokhia, M; Johnson, MR; O'Connor, GD; Chaila, E; Alhusaini, S; Shianna, KV; Radtke, RA; Heinzen, EL; Walley, N; Pandolfo, M; Pichler, W; Park, BK; Depondt, C; Sisodiya, SM; Goldstein, DB; Deloukas, P; Delanty, N; Cavalleri, GL; Pirmohamed, M (2011 թ․ մարտի 24). «HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans». The New England Journal of Medicine. 364 (12): 1134–43. doi:10.1056/nejmoa1013297. PMC 3113609. PMID 21428769.
Tohkin, M; Kaniwa, N; Saito, Y; Sugiyama, E; Kurose, K; Nishikawa, J; Hasegawa, R; Aihara, M; Matsunaga, K; Abe, M; Furuya, H; Takahashi, Y; Ikeda, H; Muramatsu, M; Ueta, M; Sotozono, C; Kinoshita, S; Ikezawa, Z; Japan Pharmacogenomics Data Science, Consortium (February 2013). «A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients». The pharmacogenomics journal. 13 (1): 60–9. doi:10.1038/tpj.2011.41. PMID 21912425.
Schwartz, RA; McDonough, PH; Lee, BW (Aug 2013). «Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment». Journal of the American Academy of Dermatology. 69 (2): 187.e1-16, quiz 203–4. doi:10.1016/j.jaad.2013.05.002. PMID 23866879.
Zajicek, R; Pintar, D; Broz, L; Suca, H; Königova, R (May 2012). «Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008». Journal of the European Academy of Dermatology and Venereology : JEADV. 26 (5): 639–43. doi:10.1111/j.1468-3083.2011.04143.x. PMID 21668825.
Rajaratnam R, Mann C, Balasubramaniam P, և այլք: (December 2010). «Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre». Clin. Exp. Dermatol. 35 (8): 853–62. doi:10.1111/j.1365-2230.2010.03826.x. PMID 20456393.
Quinn AM; Brown, K; Bonish, BK; Curry, J; Gordon, KB; Sinacore, J; Gamelli, R; Nickoloff, BJ; և այլք: (2005). «Uncovering histological criteria with prognostic significance in toxic epidermal necrolysis». Arch Dermatol. 141 (6): 683–7. doi:10.1001/archderm.141.6.683. PMID 15967913.
Schwartz, RA; McDonough, PH; Lee, BW (August 2013). «Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment». Journal of the American Academy of Dermatology. 69 (2): 187.e1-16, quiz 203–4. doi:10.1016/j.jaad.2013.05.002. PMID 23866879.
DeMers, G; Meurer, WJ; Shih, R; Rosenbaum, S; Vilke, GM (December 2012). «Tissue plasminogen activator and stroke: review of the literature for the clinician». The Journal of emergency medicine. 43 (6): 1149–54. doi:10.1016/j.jemermed.2012.05.005. PMID 22818644.

ghr.nlm.nih.gov

«Stevens-Johnson syndrome/toxic epidermal necrolysis». Genetics Home Reference (անգլերեն). July 2015. Արխիվացված է օրիգինալից 2017 թ․ ապրիլի 27-ին. Վերցված է 2017 թ․ ապրիլի 26-ին.

rarediseases.info.nih.gov

«Stevens-Johnson syndrome». GARD. Արխիվացված է օրիգինալից 2016 թ․ օգոստոսի 28-ին. Վերցված է 2016 թ․ օգոստոսի 26-ին.

ncbi.nlm.nih.gov

McCormack, M; Alfirevic, A; Bourgeois, S; Farrell, JJ; Kasperavičiūtė, D; Carrington, M; Sills, GJ; Marson, T; Jia, X; de Bakker, PI; Chinthapalli, K; Molokhia, M; Johnson, MR; O'Connor, GD; Chaila, E; Alhusaini, S; Shianna, KV; Radtke, RA; Heinzen, EL; Walley, N; Pandolfo, M; Pichler, W; Park, BK; Depondt, C; Sisodiya, SM; Goldstein, DB; Deloukas, P; Delanty, N; Cavalleri, GL; Pirmohamed, M (2011 թ․ մարտի 24). «HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans». The New England Journal of Medicine. 364 (12): 1134–43. doi:10.1056/nejmoa1013297. PMC 3113609. PMID 21428769.

orpha.net

«Orphanet: Toxic epidermal necrolysis». Orphanet (անգլերեն). November 2008. Արխիվացված է օրիգինալից 2017 թ․ ապրիլի 27-ին. Վերցված է 2017 թ․ ապրիլի 26-ին.

web.archive.org

«Stevens-Johnson syndrome/toxic epidermal necrolysis». Genetics Home Reference (անգլերեն). July 2015. Արխիվացված է օրիգինալից 2017 թ․ ապրիլի 27-ին. Վերցված է 2017 թ․ ապրիլի 26-ին.
«Orphanet: Toxic epidermal necrolysis». Orphanet (անգլերեն). November 2008. Արխիվացված է օրիգինալից 2017 թ․ ապրիլի 27-ին. Վերցված է 2017 թ․ ապրիլի 26-ին.
«Stevens-Johnson syndrome». GARD. Արխիվացված է օրիգինալից 2016 թ․ օգոստոսի 28-ին. Վերցված է 2016 թ․ օգոստոսի 26-ին.
Garra, GP (2007). "Toxic Epidermal Necrolysis Արխիվացված 2007-12-27 Wayback Machine". Emedicine.com. Retrieved on December 13, 2007.

wiley.com

onlinelibrary.wiley.com

Rajaratnam R, Mann C, Balasubramaniam P, և այլք: (December 2010). «Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre». Clin. Exp. Dermatol. 35 (8): 853–62. doi:10.1111/j.1365-2230.2010.03826.x. PMID 20456393.

worldcat.org

Maverakis, Emanual; Wang, Elizabeth A.; Shinkai, Kanade; Mahasirimongkol, Surakameth; Margolis, David J.; Avigan, Mark; Chung, Wen-Hung; Goldman, Jennifer; Grenade, Lois La (2017 թ․ հունիսի 1). «Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group». JAMA Dermatology. 153 (6): 587–592. doi:10.1001/jamadermatol.2017.0160. ISSN 2168-6068.
Majumdar, Samit; Mockenhaupt, Maja; Roujeau, Jean-Claude; Townshend, Askari P (2002 թ․ հոկտեմբերի 21). «Interventions for toxic epidermal necrolysis». Cochrane Database of Systematic Reviews (անգլերեն). doi:10.1002/14651858.CD001435. ISSN 1465-1858.